BioAdvance News Portfolio News Renovacor

Anne Prener, M.D., Ph.D. Appointed to Renovacor Board of Directors and Scientific Advisory Board

By WebmasterFebruary 24, 2020November 1st, 2024No Comments

Anne Prener, M.D., Ph.D. Appointed to Renovacor Board of Directors and Scientific Advisory Board
Former CEO of Freeline Therapeutics, Ltd. has outstanding international drug development, commercialization expertise, with focus on rare disease, gene therapy

See more here

Previous PostThis isn't a 'biotech bubble,' it's 'Philadelphia's moment' to become a center for gene therapy, says Penn-based CEO
Next PostAnnovis Issued Patent for Method of Treating Parkinson's Disease and Other Lewy Body Diseases

Anne Prener, M.D., Ph.D. Appointed to Renovacor Board of Directors and Scientific Advisory Board

SEARCH

TOPICS

ARCHIVES

RECENT POSTS

Previous PostThis isn't a 'biotech bubble,' it's 'Philadelphia's moment' to become a center for gene therapy, says Penn-based CEO

Next PostAnnovis Issued Patent for Method of Treating Parkinson's Disease and Other Lewy Body Diseases